1. Home
  2. FLXS vs SLN Comparison

FLXS vs SLN Comparison

Compare FLXS & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flexsteel Industries Inc.

FLXS

Flexsteel Industries Inc.

N/A

Current Price

$46.02

Market Cap

247.7M

ML Signal

N/A

Logo Silence Therapeutics Plc American Depository Share

SLN

Silence Therapeutics Plc American Depository Share

N/A

Current Price

$6.98

Market Cap

236.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FLXS
SLN
Founded
2001
1994
Country
United States
United Kingdom
Employees
N/A
116
Industry
Home Furnishings
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
247.7M
236.2M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
FLXS
SLN
Price
$46.02
$6.98
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$42.60
AVG Volume (30 Days)
28.9K
195.9K
Earning Date
05-01-2026
01-01-0001
Dividend Yield
1.71%
N/A
EPS Growth
85.86
N/A
EPS
2.49
N/A
Revenue
$441,073,000.00
N/A
Revenue This Year
$5.10
N/A
Revenue Next Year
$3.56
N/A
P/E Ratio
$18.81
N/A
Revenue Growth
6.86
N/A
52 Week Low
$29.38
$1.97
52 Week High
$59.95
$7.78

Technical Indicators

Market Signals
Indicator
FLXS
SLN
Relative Strength Index (RSI) 40.15 72.43
Support Level $43.52 $5.79
Resistance Level $47.99 $7.40
Average True Range (ATR) 2.56 0.57
MACD -1.25 0.18
Stochastic Oscillator 14.65 94.53

Price Performance

Historical Comparison
FLXS
SLN

About FLXS Flexsteel Industries Inc.

Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: